These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7956736)

  • 1. Pharmacokinetics of RU44403, an active form of newly developed angiotensin-converting enzyme inhibitor (RU44570) in the rat.
    Hirayama M; Kurihara A; Manabe T; Hasegawa Y
    Drug Metab Dispos; 1994; 22(4):601-6. PubMed ID: 7956736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trandolapril: pharmacokinetics of single oral doses in healthy male volunteers.
    Lenfant B; Mouren M; Bryce T; De Lauture D; Strauch G
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S38-43. PubMed ID: 7527100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of idrapril in rats, dogs, and humans.
    Criscuoli M; Lippi A; Mengozzi G; Sardelli G; Subissi A; Giachetti A
    Drug Metab Dispos; 1993; 21(5):835-40. PubMed ID: 7902245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteers.
    Emmons GT; Argenti R; Martin LL; Martin NE; Jensen BK
    J Clin Pharmacol; 2004 Aug; 44(8):901-5. PubMed ID: 15286094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat in healthy cats.
    Desmoulins PO; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2008 Aug; 31(4):349-58. PubMed ID: 18638296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.
    Nordström M; Abrahamsson T; Ervik M; Forshult E; Regårdh CG
    J Pharmacol Exp Ther; 1993 Jul; 266(1):147-52. PubMed ID: 8331554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril.
    Bevan EG; McInnes GT; Aldigier JC; Conte JJ; Grunfeld JP; Harper SJ; Meyer BH; Pauly N; Wilkinson R
    Br J Clin Pharmacol; 1993 Feb; 35(2):128-35. PubMed ID: 8443030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitor.
    Grislain L; Mocquard MT; Dabe JF; Bertrand M; Luijten W; Marchand B; Resplandy G; Devissaguet M
    Xenobiotica; 1990 Aug; 20(8):787-800. PubMed ID: 2219962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
    Colletti AE; Krieter PA
    Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution kinetics of a new nonsteroidal 5 alpha-reductase [correction of 5 A-reductase] inhibitor, 4-[3-[3-[bis(4-isobutylphenyl)methylamino]benzoyl]-1H-indol-1-YL ]-butyric acid, in rats.
    Katashima M; Yamamoto K; Haraguchi K; Tokuma Y; Hata T; Sawada Y; Iga T
    Drug Metab Dispos; 1997 Sep; 25(9):1051-8. PubMed ID: 9311620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Luffer-Atlas D; Karanam BV; McGowan E; Cioffe C; Doss G; Chiu SH
    Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model.
    Francis RJ; Brown AN; Kler L; Fasanella d'Amore T; Nussberger J; Waeber B; Brunner HR
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):32-8. PubMed ID: 2434791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo.
    Ryan JW; Valido FA; Sequeira MJ; Chung AY; Berryer P; Chen XL; Catravas JD
    J Pharmacol Exp Ther; 1994 Jul; 270(1):260-8. PubMed ID: 8035324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.